Drug Cocktail Inhibits Tumor Growth

Syrosingopine (O-carbethoxysyringoyl methylreserpate; SU-3118), a drug derived from reserpine* which was originally developed by Ciba (now Novartis) for the treatment of hypertension in 1958, in combination with the widely...

Specific Class of Biomarkers May help Take Uncertainty Out of Cancer Prognosis

A cancer diagnosis is a terrifying experience, and for most patients the associated uncertainty is especially frightening. Researchers at Cold Spring Harbor Laboratory in Cold Spring Harbor, New York,...

Focused Ultrasound-assisted Treatment helps drugs Cross Blood Brain Barrier

Study results of a research team led by scientists at the Massachusetts General Hospital (MGH), Boston, Massachusetts, shows, for the first time, the mechanisms underlying the use of Focused...

Supreme Court Justice Ruth Bader Ginsburg has Malignant Lung Nodules Removed

Today, Supreme Court Justice Ruth Bader Ginsburg, 85, underwent a lung procedure to remove malignant lung nodules. Doctors discovered the nodules during tests to treat rib fractures from a...

INmune Bio Receives Phase I Clinical Trial Authorization for Lead Product in Ovarian Cancer

INmune Bio, a clinical-stage biotechnology company developing anti-cancer therapies to reprogram the innate immune system to fight disease, has received Clinical Trial Authorization (CTA) by the United Kingdom regulatory...

Rakuten Aspyrian Raises US $284 Million Series C Financing; Develops Photoimmunotherapy Platform

Privately funded clinical stage biotechnology company Rakuten Aspyrian has raised an additional $134 million in a second tranche of its Series C financing, bringing the total amount raised to...